Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

China flag China · Delayed Price · Currency is CNY
33.47
+1.89 (5.98%)
Jul 15, 2026, 3:00 PM CST
Market Cap3.92B +0.3%
Revenue (ttm)326.02M -6.9%
Net Income-32.78M
EPS-0.26
Shares Out 124.13M
PE Ration/a
Forward PEn/a
Dividend2.30 (7.26%)
Ex-Dividend DateSep 11, 2025
Volume3,326,780
Open31.72
Previous Close31.58
Day's Range31.44 - 34.40
52-Week Range28.89 - 63.51
Beta0.70
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. In addition, the company offers biological technology ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 581
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688399
Full Company Profile

Financial Performance

In 2025, SHA:688399's revenue was 339.05 million, a decrease of -3.02% compared to the previous year's 349.61 million. Losses were -41.08 million, 1952.2% more than in 2024.

Financial Statements